# QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology

> **NCT06143696** · NA · UNKNOWN · sponsor: **Yun Chen** · enrollment: 60 (estimated)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Qingxin Zishen decoction
- **DRUG:** Femoston

## Key facts

- **NCT ID:** NCT06143696
- **Lead sponsor:** Yun Chen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06143696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06143696, "QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06143696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*